Skip to content

The effect of Omega3 supplementation on uremic pruritus and sleep quality

The effect of Omega3 on uremic pruritus and sleep quality in patients treated with hemodialysis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017040433206N1
Enrollment
52
Registered
2017-05-10
Start date
2017-05-05
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

end stage renal desease. renal end stage(failer

Interventions

Intervention 1: Intervention group receive omega 3 g 3 times a day and Cetirizine 5 mg 3 times a week for 6 weeks, and control group receive standard treatment (Cetirizine 5 mg 3 times a week) for 6
Treatment - Drugs
Intervention group receive omega 3 g 3 times a day and Cetirizine 5 mg 3 times a week for 6 weeks, and control group receive standard treatment (Cetirizine 5 mg 3 times a week) for 6 weeks will rece
Control group: standard treatment with Cetirizine 5 mg, 3 times a week for 6 weeks to receive.

Sponsors

Vice Chancellor for Research and Technological Sciences anymore
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The inclusion criteria: 1. Age over 18 years 2. patients with chronic renal failure 3. The dialysis time per session, frequency of dialysis per week are the same in both groups. Exclusion criteria: 1. patients younger than 18 years 2. Patients who have used other anti-itch medication and treatment has been effective. 3. The patient's unwillingness to continue the research. 4-malabsorption or any digestive problems (such as chronic diarrhea more than 2 weeks). 5. skin disease that cause itching dermatologist discretion and is not related uremic pruritus. 6. contraindicated antihistamines (blurred vision, glaucoma, prostate, dementia, neurological disorders -Zlany) 7. received drugs or treatments that have the same itch topical emollients, UV rays and effective. 8Sensitivity to omega-3. 9. The patient died

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Uremic pruritus. Timepoint: 3 times (baseline, 6 weeks after the intervention, and at the end of the study). Method of measurement: 35/5000 Did you mean: ???????? ???? ????????? Save Reset Itching questionnaire Yvsypvych.

Secondary

MeasureTime frame
Sleep quality. Timepoint: 3 times (baseline, 6 weeks after the end of the study). Method of measurement: Pittsburgh Sleep Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactmansooreh heydarbeyki

School of Nursing and Midwifery University of Medical Sciences King

elmira139207@gmail.com+98 23 3239 5054

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026